קרסטור 20 מ"ג - Crestor 20 mg
×××× ×× ×× × ×ספ×× ×©× ×§×¨×¡××ר - Crestor
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ××× ×× ×× × ×ספ×× | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ×§×××¦× ×¤×¨××§×××××ת (ATC4) | C10AA HMG CoA reductase inhibitors | ||||||||||||||||||
| ×ר××× ×¤×¢×× (ATC5) | Â
| ||||||||||||||||||
| צ×רת ××ª× | פ××× - PER OS | ||||||||||||||||||
| צ×רת ××× ×× | ×××××ת ×צ×פ×ת פ×××, FILM COATED TABLETS ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× | ||||||||||||||||||
| ×ת×××× | Primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate. Homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate.
| ||||||||||||||||||
| |||||||||||||||||||
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
  | ||||||||||||||||||
| ×¢××× ×צר×× |  |
|---|
| ער××× ×××××§×רפ××× | ער××× ×§×©×ר×× ×××××§×רפ××× |
|---|---|
| קרס××ר 20 ×"× ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | ASTRA ZENECA UK LIMITED |
| ×©× ××¢× ×ר×ש×× | ASTRA ZENECA (ISRAEL) LTD |
| ר×ש××× | ת×ר×× ××ש×: 05/2003. ר×ש××× ×ת×ר××: 08/2013 |
| ת×ר×× ×¢×××× ××ר×× | 14/05/19 |
× ×ª×× × ×¡×
| × ×ª×× × ××¡× | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ת×ר×× ××××× ×ס×
| ||||||||||||
×××××ת ×ס×
| ||||||||||||
×ת×××× ×ס×
| ||||||||||||
| ש×××ש ××¡× | ||||||||||||
| ×ס×רת ××××× ××¡× |
השינוי האחרון נעשה בֹ־29 בדצמבר 2013 ב־07:28